Blend Labs Inc (BLND) concluded trading on Wednesday at a closing price of $3.69, with 5.56 million shares of worth about $20.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 5.43% during that period and on March 12, 2025 the price saw a gain of about 11.14%. Currently the company’s common shares owned by public are about 254.43M shares, out of which, 204.16M shares are available for trading.
Stock saw a price change of 18.65% in past 5 days and over the past one month there was a price change of -7.29%. Year-to-date (YTD), BLND shares are showing a performance of -12.35% which increased to 19.03% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.08 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Blend Labs Inc shares is 3.38 million. The stock is currently trading 5.47% above its 20-day simple moving average (SMA20), while that difference is down -0.10% for SMA50 and it goes to 1.90% higher than SMA200.
Blend Labs Inc (NYSE: BLND) currently have 254.43M outstanding shares and institutions hold larger chunk of about 51.74% of that.
The stock has a current market capitalization of $944.38M and its 3Y-monthly beta is at 1.29. It has posted earnings per share of -$0.24 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 7.29% while standing at 6.64% over the month.
Analysts are in expectations that Blend Labs Inc (BLND) stock would likely to be making an EPS of -0.01 in the current quarter, while forecast for next quarter EPS is 0.02 and it is 0.12 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.01 which is 0.0 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.06 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 139.28% while it is estimated to increase by 131.85% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on December 18, 2024 offering a Mkt outperform rating for the stock and assigned a target price of $7 to it. Coverage by Canaccord Genuity stated Blend Labs Inc (BLND) stock as a Buy in their note to investors on August 12, 2024, suggesting a price target of $4.75 for the stock. On August 09, 2024, William Blair Upgrade their recommendations, while on December 20, 2023, Wells Fargo Upgrade their ratings for the stock with a price target of $3.50. Stock get a Mkt perform rating from Keefe Bruyette on November 14, 2022.
